Analystreport

Theravance Biopharma, Inc. (NASDAQ: TBPH) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "underweight" rating.

Theravance Biopharma, Inc. - Ordinary Shares  (TBPH) 
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.theravance.com/investor-relations